• Mashup Score: 1

    Read American College of Rheumatology recommendations for the treatment and management of lupus.

    Tweet Tweets with this article
    • The ACR reopened the call for letters of interest (LOI) for an evidence-based clinical practice guideline project that was recently broadened from #lupusnephritis to all of #lupus. The LOI submission deadline is Wednesday, July 5. Details → https://t.co/CQjnXHo3Uz https://t.co/TW9vqbfOum

  • Mashup Score: 1

    Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee

    Tweet Tweets with this article
    • #Lupus #Science & #Medicine and @LupusOrg Dr. Anna Wolska interviews Dr. Andrea Fava from @JohnHopkinsUni1 about #Belimumab treatment in lupus #nephritis. #SLE #Rheumatology #EULAR2023 #LupusNephritis #Treatment #Biomarker #precisionmedicine #trials https://t.co/w4ZzAavQ8F

  • Mashup Score: 0

    Discover how you can apply the concept of disease modification in lupus and lupus nephritis to help treat patients in your clinical practice. View our infographic and walk through an interactive patient journey towards disease modification. Also, listen to leading expert Dr. Michelle Petri to learn about scientific advances in monitoring for renal damage accrual in lupus nephritis.

    Tweet Tweets with this article
    • View an interactive disease modification patient journey from the #LupusEducatorsNetwork and learn about the importance of helping to prevent renal damage in your patients with #LupusNephritis. #SponsoredbyGSKUSMA https://t.co/QDMvYpAzWQ https://t.co/ONr3KBEsPN

  • Mashup Score: 1

    Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee

    Tweet Tweets with this article
    • #Lupus #Science & #Medicine and @LupusOrg Dr. Anna Wolska interviews Dr. Andrea Fava from @JohnHopkinsUni1 about #Belimumab treatment in lupus #nephritis. #SLE #Rheumatology #EULAR2023 #LupusNephritis #Treatment #Biomarker #precisionmedicine #trials https://t.co/w4ZzAavQ8F

  • Mashup Score: 1

    Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee

    Tweet Tweets with this article
    • #Lupus #Science & #Medicine and @LupusOrg Dr. Anna Wolska interviews Dr. Andrea Fava from @JohnHopkinsUni1 about #Belimumab treatment in lupus #nephritis. #SLE #Rheumatology #EULAR2023 #LupusNephritis #Treatment #Biomarker #precisionmedicine #trials https://t.co/w4ZzAavQ8F

  • Mashup Score: 0

    Discover how you can apply the concept of disease modification in lupus and lupus nephritis to help treat patients in your clinical practice. View our infographic and walk through an interactive patient journey towards disease modification. Also, listen to leading expert Dr. Michelle Petri to learn about scientific advances in monitoring for renal damage accrual in lupus nephritis.

    Tweet Tweets with this article
    • View our infographic from the #LupusEducatorsNetwork and discover how you can apply the concept of #DiseaseModification in #Lupus and #LupusNephritis to help treat patients in your clinical practice #SponsoredbyGSKUSMA https://t.co/fzspfwarK4 https://t.co/jXNte7f0sY

  • Mashup Score: 0

    Discover how you can apply the concept of disease modification in lupus and lupus nephritis to help treat patients in your clinical practice. View our infographic and walk through an interactive patient journey towards disease modification. Also, listen to leading expert Dr. Michelle Petri to learn about scientific advances in monitoring for renal damage accrual in lupus nephritis.

    Tweet Tweets with this article
    • View an interactive disease modification patient journey from the #LupusEducatorsNetwork and learn about the importance of helping to prevent renal damage in your patients with #LupusNephritis. #SponsoredbyGSKUSMA https://t.co/6ffl0UOuGh https://t.co/HqZNZq9dCI

  • Mashup Score: 4

    Discover how you can apply the concept of disease modification in lupus and lupus nephritis to help treat patients in your clinical practice. View our infographic and walk through an interactive patient journey towards disease modification. Also, listen to leading expert Dr. Michelle Petri to learn about scientific advances in monitoring for renal damage accrual in lupus nephritis.

    Tweet Tweets with this article
    • View our infographic from the #LupusEducatorsNetwork and discover how you can apply the concept of #DiseaseModification in #Lupus and #LupusNephritis to help treat patients in your clinical practice #SponsoredbyGSKUSMA https://t.co/BSXVU57A1K https://t.co/63FZvveDnL